Bronnen:
- El-Khoueiry AB, Sangro B, Yau T, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial. Lancet. 2017;389:2492-2502.
Bronnen:
dec 2023 | Uro-oncologie
dec 2022 | Maag-darm-leveroncologie
okt 2021 | Uro-oncologie
jun 2021 | Chirurgie, Maag-darm-leveroncologie
feb 2021 | Maag-darm-leveroncologie
mrt 2024
nov 2023
sep 2023